CRT 2026
Valve and Structural
Jeffrey J. Popma, MD
Chief Scientific Officer
CRF
Newton, Massachusetts, United States
Disclosure(s): Medtronic: CMO ended Nov 2024 (Terminated, November 1, 2024), Stock-publicly held company (excluding mutual/index funds) (Terminated, November 1, 2024)
Anita W. Asgar, MD, FACC, FSCAI
Interventional Cardiologist
Northwestern Medicine
Chicago, Illinois, United States
Disclosure information not submitted.
Vinayak Bapat, FRCS(CTh)
Consultant
Abbott Northwestern Hospital & Minneapolis Heart Foundation
Minneapolis, Minnesota, United States
Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)
Rishi Puri, MBBS PhD FRACP
Staff Structural and Coronary Interventionalist
Cleveland Clinic
Cleveland Heights, Ohio, United States
Disclosure(s): No financial relationships to disclose
Paul D. Mahoney, MD, FACC, FSCAI
Chief, Interventional Cardiology, Director, Structural Heart Program
ECU Health
Greenville, North Carolina, United States
Disclosure information not submitted.
Michael J. Reardon, MD
Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States
Disclosure(s): BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); High Life: Consulting Fees (e.g., advisory boards) (Ongoing); JValve: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); WL Gore & Associates: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)